Self‐assembled methoxy poly(ethylene glycol)–cholesterol micelles for hydrophobic drug delivery. Issue 3 (29th December 2012)

• Record Type: Journal Article
• Authors: Yu, Yiyi; He, Yingju; Xu, Bei; He, Zhiyao; Zhang, Ying; Chen, Yan; Yang, Yang; Xie, Yongmei; Zheng, Yu; He, Gu; He, Jun; Song, Xiangrong
• Is Part Of: Journal of pharmaceutical sciences. Volume 102:Issue 3(2013:Mar.)
• Page Start: 1054
• Page End: 1062
• Publication Date: 2012-12-29
• Subjects: Pharmacy -- Periodicals; 615.1
• DOI: 10.1002/jps.23418
• Languages: English
• ISSNs: 0022-3549

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>To promote the application of methoxy poly(ethylene glycol)–cholesterol (mPEG–Chol), mPEG–Chol was used to prepare core–shell micelles encapsulating poorly water‐soluble docetaxel (DTX‐PM) by modified cosolvent evaporation method. Approaches to enhance DTX entrapment efficiency (EE) and minimize particle size were investigated in detail, including organic and aqueous phase composition, organic/aqueous phase ratio, and polymer concentration. In optimal formulation, micelles had higher EE (97.6%) and drug loading (4.76%) with the diameter of 13.76 ± 0.68 nm and polydispersity index of 0.213 ± 0.006. Transmission electron microscopy (TEM) showed that the micelles were spherical, and differential scanning calorimetry (DSC) analysis proved that DTX was successfully entrapped into mPEG–Chol micelles. The <italic>in vitro</italic> cytotoxicity experiments displayed that blank micelles had no effect on the growth of SKOV‐3, BXPC‐3, A549, and HepG‐2 cells, demonstrating that mPEG–Chol was one of the biocompatible biomaterials. The half inhibition concentration of DTX‐PM on SKOV‐3, BXPC‐3, A549, and HepG‐2 cells were 10.08, 7.6, 28.37, and 125.75 ng/mL, respectively. DTX‐PM had the similar antitumor activity to free DTX, indicating that mPEG–Chol was a promising micellar vector for hydrophobic drug delivery. In addition, this work provided a new and facile approach to prepare drug‐loaded micelles with controllable performances. © 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:1054–1062, 2013</p> </abstract>